1 Study Coverage
1.1 Precision Cancer Therapies Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million) Introduction
1.2 Global Precision Cancer Therapies Outlook 2017 VS 2022 VS 2028
1.2.1 Global Precision Cancer Therapies Market Size for the Year 2017-2028
1.2.2 Global Precision Cancer Therapies Market Size for the Year 2017-2028
1.3 Precision Cancer Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Precision Cancer Therapies in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Precision Cancer Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Precision Cancer Therapies Market Dynamics
1.4.1 Precision Cancer Therapies Industry Trends
1.4.2 Precision Cancer Therapies Market Drivers
1.4.3 Precision Cancer Therapies Market Challenges
1.4.4 Precision Cancer Therapies Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Precision Cancer Therapies by Type
2.1 Precision Cancer Therapies Market Segment by Type
2.1.1 Hormone Therapy
2.1.2 Immunotherapies
2.1.3 Targeted Therapy
2.1.4 Monoclonal Antibody Therapy
2.1.5 Gene Therapy
2.2 Global Precision Cancer Therapies Market Size by Type (2017, 2022 & 2028)
2.3 Global Precision Cancer Therapies Market Size by Type (2017-2028)
2.4 United States Precision Cancer Therapies Market Size by Type (2017, 2022 & 2028)
2.5 United States Precision Cancer Therapies Market Size by Type (2017-2028)
3 Precision Cancer Therapies by Application
3.1 Precision Cancer Therapies Market Segment by Application
3.1.1 Hospitals
3.1.2 Diagnostic Centers
3.1.3 Oncology Clinics
3.1.4 Research Institutes
3.2 Global Precision Cancer Therapies Market Size by Application (2017, 2022 & 2028)
3.3 Global Precision Cancer Therapies Market Size by Application (2017-2028)
3.4 United States Precision Cancer Therapies Market Size by Application (2017, 2022 & 2028)
3.5 United States Precision Cancer Therapies Market Size by Application (2017-2028)
4 Global Precision Cancer Therapies Competitor Landscape by Company
4.1 Global Precision Cancer Therapies Market Size by Company
4.1.1 Top Global Precision Cancer Therapies Companies Ranked by Revenue (2021)
4.1.2 Global Precision Cancer Therapies Revenue by Player (2017-2022)
4.2 Global Precision Cancer Therapies Concentration Ratio (CR)
4.2.1 Precision Cancer Therapies Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Precision Cancer Therapies in 2021
4.2.3 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Precision Cancer Therapies Headquarters, Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million) Type
4.3.1 Global Precision Cancer Therapies Headquarters and Area Served
4.3.2 Global Precision Cancer Therapies Companies Revenue in Precision Cancer Therapies Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Precision Cancer Therapies Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Precision Cancer Therapies Market Size by Company
4.5.1 Top Precision Cancer Therapies Players in United States, Ranked by Revenue (2021)
4.5.2 United States Precision Cancer Therapies Revenue by Players (2020, 2021 & 2022)
5 Global Precision Cancer Therapies Market Size by Region
5.1 Global Precision Cancer Therapies Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Precision Cancer Therapies Market Size by Region (2017-2028)
5.2.1 Global Precision Cancer Therapies Market Size by Region: 2017-2022
5.2.2 Global Precision Cancer Therapies Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Precision Cancer Therapies Market Size YoY Growth 2017-2028
6.1.2 North America Precision Cancer Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Precision Cancer Therapies Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Precision Cancer Therapies Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Precision Cancer Therapies Market Size YoY Growth 2017-2028
6.3.2 Europe Precision Cancer Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Precision Cancer Therapies Market Size YoY Growth 2017-2028
6.4.2 Latin America Precision Cancer Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Precision Cancer Therapies Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Precision Cancer Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Details
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
7.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2017-2022)
7.1.5 Abbott Laboratories Recent Development
7.2 Bayer HealthCare
7.2.1 Bayer HealthCare Company Details
7.2.2 Bayer HealthCare Business Overview
7.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
7.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2017-2022)
7.2.5 Bayer HealthCare Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Details
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
7.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2017-2022)
7.3.5 GlaxoSmithKline Recent Development
7.4 OncoGenex Pharmaceuticals
7.4.1 OncoGenex Pharmaceuticals Company Details
7.4.2 OncoGenex Pharmaceuticals Business Overview
7.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
7.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2017-2022)
7.4.5 OncoGenex Pharmaceuticals Recent Development
7.5 Hospira
7.5.1 Hospira Company Details
7.5.2 Hospira Business Overview
7.5.3 Hospira Precision Cancer Therapies Introduction
7.5.4 Hospira Revenue in Precision Cancer Therapies Business (2017-2022)
7.5.5 Hospira Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Details
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
7.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2017-2022)
7.6.5 Boehringer Ingelheim Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Details
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Precision Cancer Therapies Introduction
7.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2017-2022)
7.7.5 AstraZeneca Recent Development
7.8 Aveo Pharmaceuticals
7.8.1 Aveo Pharmaceuticals Company Details
7.8.2 Aveo Pharmaceuticals Business Overview
7.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
7.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2017-2022)
7.8.5 Aveo Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
